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Abstract
Cholesterol is a multifaceted molecule, which serves as essential membrane component, as cofactor for signaling molecules and as
precursor for steroid hormones. Consequently, defects in cholesterol metabolism cause devastating diseases. So far, the role of cholesterol in
the nervous system is less well understood. Recent studies showed that cultured neurons from the mammalian central nervous system (CNS)
require glia-derived cholesterol to form numerous and efficient synapses. This suggests that the availability of cholesterol in neurons limits
the extent of synaptogenesis. Here, I will summarize the experimental evidence for this hypothesis, describe what is known about the
structural and functional role of cholesterol at synapses, and discuss how cholesterol may influence synapse development and stability.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cholesterol is a remarkably versatile molecule [1]. It
determines the biophysical properties of cellular membranes
[2], serves as precursor for steroid hormones and regulates the
function of signaling molecules like hedgehog [3]. Given this
multitude of functions, it is not surprising that acquired or
genetic defects in cholesterol metabolism cause severe dis-
eases [4–8] including arteriosclerosis [9,10], Smith–Lemli–
Opitz syndrome [11] and Niemann–Pick type C disease [12].
Despite the intense research on cholesterol, surprisingly little
is known about its role in nervous systems (for reviews on
brain cholesterol, see Refs. [13–19]). A recent study raises
the possibility that cholesterol may be a limiting factor for
synaptogenesis in the CNS [20] (for reviews, see Refs. [21–
24]). Here, I will present experimental evidence for this
hypothesis, summarize current notions about the structural
and functional role of cholesterol at synapses, and discuss
how this molecule may influence their development.
2. Experimental evidence for a link between cholesterol
and synapse development
The idea of a connection between synaptogenesis and
cholesterol has been provoked by a series of studies that
aimed to test whether glial cells play a role in synapse
formation [20,25–27]. This question was prompted by the
fact that during brain development most synapses are
formed after the differentiation of astrocytes [28,29].
2.1. First evidence for a glial role in synapse development
Pfrieger and Barres [25] investigated whether neurons
form synapses in the absence of glial cells in cultures of
highly purified retinal ganglion cells (RGCs) [30] growing
under defined conditions [31]. They found that glial cells
drastically enhanced the level of spontaneous excitatory
synaptic activity and the efficacy of evoked synaptic trans-
mission. Notably, these effects were mediated by one or more
soluble factors released by astrocytes and oligodendrocytes.
A series of experiments showed that the changes were not
caused indirectly by an increase in neuronal survival or
excitability. Furthermore, RGCs formed ultrastructurally
defined synaptic connections even in the absence of glial
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cells. This observation proved that neurons have an innate
ability to form synapses and do not require external signals
from glial cells or from postsynaptic partners. However, the
study of Pfrieger and Barres raised several important ques-
tions: Do glial cells promote the formation of synapses? Do
they enhance the efficacy of existing connections? And,
probably most importantly, what is the glia-derived factor?
2.2. Glial factors enhance synapse formation
The question whether glial cells enhance the formation of
synapses was addressed in microcultures of RGCs [26,27].
Microcultures allow for a quantitative approach to synapto-
genesis, as the number and functional properties of synapses
can be defined per single neuron. Immunocytochemical
staining showed that treatment with glia-conditionedmedium
(GCM) increased the number of synapses formed by RGCs
by about seven-fold [26]. This finding was corroborated by
immunocytochemical and electron microscopic data of
Ullian et al. [27]. The observed increase in synapse number
exceeded the value determined by the previous ultrastructural
analysis of Pfrieger and Barres [25]. Notably, the changes
were not due to a general increase in the expression of
synaptic proteins [27] (Mauch, D.H. and Pfrieger, F.W.,
unpublished data) or an increase in neurite outgrowth [20],
indicating that glia indeed promote synapse formation.
2.3. Glial factors enhance synaptic efficacy pre- and
postsynaptically
Using FM1–43 labeling of active terminals and electro-
physiological recordings of autaptic currents, Na¨gler et al.
[26] showed that glial factors also enhance the efficacy of
presynaptic transmitter release: Treatment of microcultures
with GCM accelerated the stimulation-induced loss of FM1–
43 fluorescence from individual presynaptic terminals and
strongly enhanced the frequency of asynchronous autaptic
events. Notably, the GCM-induced effects occurred in differ-
ent time windows. The reliability of evoked transmission and
the frequency of asynchronous transmitter release were en-
hanced within 24 h, whereas the frequency and size of spon-
taneous events were augmented 48 h after GCM application.
Ullian et al. [27] reported that glial cells increased the size
of glutamate-induced membrane currents in RGCs by three-
fold. This result provides direct evidence for a postsynaptic
effect and may explain why glial cells increase the ampli-
tudes of miniature excitatory postsynaptic currents [25–27].
2.4. Identification of the glial factor as cholesterol trans-
ported via lipoproteins
The reports summarized above showed that glia-derived
factors strongly promoted synapse development. Obviously,
the most pressing issue remained the identification of these
factors, as this was the key to determine their role in vivo
and to elucidate the underlying molecular mechanisms. Our
recent study [20] provides strong evidence that most of the
effects described above are mediated by cholesterol. Chro-
matographic fractionation of GCM revealed that the glial
activity migrated with large heparin-binding components
ranging in size from 160 to 670 kDa. This observation
together with the identification of apolipoprotein E (ApoE)
as GCM-derived membrane component of RGCs hinted to
components of lipoproteins as possible candidates for the
synaptogenic factor. Subsequent tests showed that choles-
terol was the active ingredient in GCM: first, the cholesterol
content in active chromatographic column fractions scaled
with their effect on synaptic activity. Second, reduction of
the cholesterol concentration in GCM by a synthesis inhib-
itor strongly reduced its synaptogenic effect. Third, blocking
lipoprotein uptake by a competitive low-density lipoprotein
(LDL)-receptor antagonist reduced the effect of GCM on
synaptic activity. Fourth, cytochemical staining of RGCs
with a cholesterol-binding drug showed that GCM raises
strongly the cholesterol content of RGCs. Finally, choles-
terol alone mimicked most of the GCM-induced effects on
autapse number and efficacy reported by Na¨gler et al. [26].
Taken together, the results suggest the following scenario
in vivo: neurons appear to produce enough cholesterol to
survive, to differentiate axons and dendrites and to form a few
and inefficient synapses. The massive formation of synapses,
however, may require additional cholesterol that must be
delivered by astrocytes via ApoE-containing lipoproteins
(Fig. 1) [24].
Fig. 1. Diagram illustrating the possible distribution and function of
cholesterol at synapses. Localization of cholesterol-rich domains (red) (1) in
synaptic vesicle membranes to mediate axonal transport via kinesin (light
blue) along microtubuli (orange-yellow rods), (2) in presynaptic active
zones to organize exocytotic complexes (green diamonds), (3) in
postsynaptic membranes to cluster neurotransmitter receptors (dark blue
ovals) or in extrasynaptic pools for activity-dependent recruitment and (4)
at the edge of synapses to promote cell adhesion (yellow rectangles).
Synapses import cholesterol from astrocytes (green membrane) via
lipoproteins (green circles) and lipoprotein receptors (orange hexagons).
F.W. Pfrieger / Biochimica et Biophysica Acta 1610 (2003) 271–280272
3. Cholesterol and synapses
This scenario raises the question of how cholesterol
influences synapse development. The simplest explanation
would be that cholesterol is an essential component of the
synaptic machinery and that its availability limits the
assembly of synaptic structures. To explore this possibility,
I will review what is known about the cholesterol content in
different synaptic compartments and its influence on pre-
and postsynaptic function (Fig. 1). Cholesterol has profound
effects on the biophysical properties of membranes [2],
thereby affecting the function of membrane-resident signal-
ing components including ion channels, transporters and
receptors. This more general aspect has been summarized in
several reviews [32–36].
3.1. Cholesterol in presynaptic terminals
The release of transmitter from presynaptic terminals
requires an elaborate assembly of protein and lipid compo-
nents. Recent reports provide evidence that cholesterol is an
essential element of the exocytosis apparatus and plays a
crucial role in the biogenesis and transport of synaptic
vesicles.
3.1.1. Studies on synaptosomal preparations
The lipid composition of presynaptic terminals has been
estimated using synaptosome preparations. Synaptosomes
represent ripped-off terminals, which are purified by density
gradient centrifugation of homogenized nervous tissue
[37,38]. The cholesterol content of synaptosomes, normal-
ized to the phospholipid concentration (cholesterol to phos-
pholipid or C/P ratio), varies between 0.5 and 1 [39–43],
thus falling in the range of plasma membranes. The C/P
ratio depends on age [44–47], is influenced by disease
[48,49] and varies in different species and strains [50]. Some
of the variability in C/P ratios may be explained by the use
of different isolation methods, which determine the compo-
sition and purity of synaptosomal preparations [37]. Elec-
tron microscopic images revealed that synaptosomes contain
not only presynaptic terminals, but also postsynaptic com-
ponents [37], which contribute to the cholesterol estimate.
Therefore, synaptosomes do not allow for an accurate
determination of the cholesterol content in terminals.
Despite this limitation, synaptosomes have been used to
address other aspects. There are several studies on the
distribution of cholesterol across the phospholipid bilayer.
It has been shown that the inner leaflet of synaptic mem-
branes contains eight-fold more cholesterol than its outer
counterpart and that this distribution is affected by disease
[49] and aging [51] (for review, see Ref. [13]). Moreover,
ApoE and the LDL receptor [52,53] seem to influence the
transbilayer distribution of cholesterol in synaptic mem-
branes thus supporting the idea that lipoprotein-derived
cholesterol affects synapses [20,24]. In general, it is well
established that lipids are asymmetrically distributed across
the two bilayers (for review, see Refs. [54,55]). So far,
however, the relevance of the cholesterol asymmetry in
synaptosomal membranes is unclear. The experimental
approach to measure the transbilayer distribution relies on
the leaflet-selective quenching of fluorescent cholesterol
analoga and further studies are required to test whether
these analoga fully mimic the behavior of cholesterol in
membranes [56].
Synaptosomes have also been extensively used to deter-
mine effects of cholesterol on functional properties of
synaptic components like ion pumps and neurotransmitter
transporters [57–62], but the molecular mechanisms of
these changes remain unclear. Evidently, they may be
caused by cholesterol effects on the biophysical properties
of membranes.
3.1.2. Cholesterol distribution in presynaptic terminals
The aforementioned biochemical studies on synapto-
somes suggest a high cholesterol content in presynaptic
terminals, but they do not reveal its spatial distribution. This
topic has been addressed by freeze–fracture electron micro-
scopy. In this approach, visualization of cholesterol relies on
the fact that the polyene antibiotic filipin forms complexes
with sterols carrying a hydroxy group at the third carbon
atom. These complexes appear as protuberances in freeze–
fractured biological membranes [63]. In frog neuromuscular
junctions (NMJs) [64,65], sterol– filipin complexes are
localized in the transmitter release zone, but absent from
the adjacent area that is flanked by rows of intramembrane
particles (IMPs). A similar distribution was observed at
ribbon-type synapses between photoreceptors and bipolar
neurons of chick retina [66]. In terminals of Torpedo
electrical organ, which lack rows of IMPs, sterol–filipin
complexes are distributed in a patchy fashion [67]. Freeze–
fracture studies on synaptosomes from rat cerebral cortex
confirmed the presence of sterol– filipin complexes in
presynaptic terminals [68,69] and their absence from IMP-
rich zones[69]. Notably, Surchev et al. [69] showed that the
density of sterol complexes in presynaptic membranes
increases during postnatal development. Egea et al. [70]
reported that potassium-induced acetylcholine release
enhances the density of sterol – filipin complexes in
freeze–fracture replicas of synaptosomes from Torpedo
electric organ. This effect was abolished in low calcium
and by botulinus toxin indicating that the rearrangement was
induced by the release process itself rather than by depola-
rization or calcium influx.
Caveats concerning the use of filipin as cytochemical
marker for cholesterol need to be mentioned [71]. The
binding efficacy of filipin to cholesterol may depend on
the microenvironment. Thus, the absence of sterol–filipin
complexes from IMP-rich areas may be due to the presence
of specific microdomains, where access of filipin to choles-
terol is diminished, rather than low cholesterol content. In
addition, lateral diffusion of cholesterol in the membrane
may be faster than filipin binding, therefore leading to
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changes in subcellular cholesterol distribution before for-
mation of sterol–filipin complexes. Altogether, however,
the freeze–fracture studies show that cholesterol is present
in presynaptic release zones and that its density increases
after transmitter release.
3.1.3. Cholesterol-dependency of exocytosis
Although the presence of cholesterol in terminals is well
supported, its relevance for transmitter release has remained
elusive. This situation changed recently with two pioneering
studies providing direct evidence for a role of cholesterol in
exocytosis [72,73]. Lang et al. [72] observed in the neuron-
like cell line PC12 that docking and fusion of secretory
granules occur at syntaxin- and synaptosomal-associated
protein of 25 kDa (SNAP25)-positive clusters that are
sprinkled across the plasma membrane. Lowering the plas-
malemmal cholesterol content by methyl-h-cyclodextrin
(MCD) dispersed syntaxin clusters and inhibited KCl-
induced release of dopamine and of green fluorescent
protein-labeled neuropeptide Y, as monitored by amperom-
etry and fluorescence microscopy, respectively. The rele-
vance of cholesterol for exocytosis has been confirmed by
Chamberlain et al. [73], who observed as well that reduction
of the cellular cholesterol level reduces dopamine release
from PC12 cells. Syntaxin and SNAP25, which form the
soluble N-ethylmaleimide-sensitive factor attachment pro-
tein receptor (SNARE) complex with vesicle-associated
membrane protein (VAMP), but none of the other exocy-
tosis-relevant proteins tested partitioned to the detergent-
insoluble cholesterol-rich membrane fraction. At first sight,
this finding appears in contrast to the results of Lang et al.
[72]. However, the detergent insolubility applied only to
25% of the total syntaxin pool [73].
The main message of the two studies is that SNARE-
dependent exocytosis occurs at cholesterol-rich domains in
the plasma membrane (Fig. 1). There is increasing evidence
that such domains, further referred to as rafts, function as
dynamic modules that organize signaling components in the
plasma membrane to promote efficient signal transduction
and selective subcellular sorting [74–78]. The fact that
SNARE complexes also mediate transmitter release in
neurons suggests the presence of rafts in presynaptic termi-
nals. These rafts may give rise to the sterol–filipin bulbs
that were observed in the freeze–fracture studies mentioned
above. Finally, the cholesterol-dependence of exocytosis
may explain, at least in part, why cholesterol strongly
increases the efficacy of transmitter release in cultured
RGCs [20]. Neurons may depend on an external source of
cholesterol to assemble the exocytosis apparatus.
3.1.4. Cholesterol content of synaptic vesicles
Presynaptic transmitter release involves an interplay of
two highly specialized compartments, the membrane at the
docking zone and the membrane of synaptic vesicles. The
molecular composition of synaptic vesicles has been char-
acterized, since these organelles can be purified to a high
degree from synaptosomes due to their abundance and
uniform size [79]. Studies on isolated vesicles from rodent
brain or Torpedo electric organ revealed that their C/P ratios
range from 0.4 to 0.6 [80–84]. Thus, synaptic vesicles
contain more cholesterol than other intracellular organelles
including mitochondria or the endoplasmic reticulum [2,16].
So far, it is not known whether vesicles carrying specific
neurotransmitters differ in their lipid composition. The
arrival of methods to highly purify specific types of vesicles,
for example by immunoisolation [85], should allow us to
clarify this issue. It appears possible, however, that a high
cholesterol content is required to forge [86] and fuse
vesicles [87] regardless of their transmitter content (Fig. 1).
3.1.5. Cholesterol availability limits vesicle biogenesis and
transport
The high cholesterol content in the vesicle membrane
suggests a link between vesicle biogenesis [88] and the
cellular cholesterol level. This is supported by a study that
aimed to identify cholesterol-binding proteins using a new
photoaffinity-probe [89]. The authors compared patterns of
cholesterol-binding proteins in two PC12 clones that dif-
fered in their neurosecretory competence and identified
synaptophysin as cholesterol-binding component of synap-
tic vesicles. Importantly, they could establish that the
cholesterol level controls the availability of secretory
vesicles in PC12 cells: lowering the cellular cholesterol
content by MCD diminished the steady-state pool of syn-
aptic-like microvesicles and their rate of biogenesis, but did
not affect endocytosis in general. The reason for this
specific role of cholesterol in vesicle formation is not clear.
Cholesterol–protein interactions and cholesterol-rich micro-
domains may be necessary to induce the vesicle curvature
and to assemble vesicle-specific proteins and lipids, respec-
tively [86,90]. There is increasing evidence that lipid rafts
help to sort proteins and lipids to specific subcellular com-
partments [75–77]. Interestingly, a recent study showed that
the kinesin-mediated transport of membranes along micro-
tubuli requires cholesterol and sphingomyelin-rich rafts
[91]. This adds further support to the idea that vesicle
membranes contain cholesterol-rich rafts and suggests a
correlation between the cholesterol content of synaptic
vesicles and the efficacy of their axonal transport (Fig. 1).
The idea that cholesterol is necessary for vesicle for-
mation and transport may explain some observations on
cholesterol-treated RGC cultures [20]. Cholesterol strongly
increased the number of puncta that represented synaptic
vesicles as they were double-labeled by antibodies against
synapsin-I and synaptophysin. A cholesterol-induced
increase in synaptic vesicle production or transport could
cause the sequential enhancement of evoked and sponta-
neous autaptic activity following GCM treatment of RGC
microcultures [26]. Newly minted vesicles would first be
delivered to existing synapses. This would cause the early
drop in failure rates and the increase in asynchronous
release, since the probability of transmitter release grows
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with the number of vesicles in presynaptic terminals. Later
on, the increased vesicle pool would allow for the formation
of new synapses leading to an increase in spontaneous
release. Together, the results provoke an exciting hypoth-
esis: the number of synapses that a neuron can form may be
limited by its capacity to generate synaptic vesicles.
3.2. Cholesterol on the postsynaptic side
Research within the last years has shown that the post-
synaptic membrane (PM) and the attached postsynaptic
density (PSD) contain a vast array of protein components
to enable postsynaptic signal transduction (for reviews, see
Refs. [92–94]). Notwithstanding this progress at the protein
front, the lipid composition of the PM is still poorly under-
stood.
3.2.1. Postsynaptic components in rafts
A series of studies suggests that neurotransmitter recep-
tors and other postsynaptic components are associated with
rafts (Fig. 1). Nicotinic acetylcholine receptors (AChRs)
from cultured chick ciliary ganglion neurons were found in
raft-like microdomains, which are cholera toxin-positive and
detergent-resistant. Moreover, receptor clusters were dis-
persed by MCD-dependent cholesterol depletion, but not
by actin depolymerization [95]. AMPA-type glutamate
receptors were detected in detergent-insoluble rafts from
rat brain synaptosomes, while NMDA receptor subunits,
PSD95, glutamate-receptor interacting protein (GRIP) and
several other postsynaptic components were absent [96].
The latter finding contrasts with the detection of PSD95 [97]
and GRIP [98] in detergent-insoluble density gradient
fractions from rat cerebral cortex and from mouse brain,
respectively, but this may be due to methodological differ-
ences. The GABAB-type receptor partitioned to Triton-X
insoluble raft-like fractions from rat cerebellum in a choles-
terol-dependent manner, while the metabotropic glutamate
receptor was completely detergent-soluble [99]. Other post-
synaptic components like CASK/Lin-2 have also been
localized to rafts based on their sedimentation behavior
after density-gradient centrifugation of detergent-treated
material [100]. Together, these data suggest that rafts help
to organize the postsynaptic side thus mirroring their func-
tion at the presynaptic release zone (Fig. 1). Since raft
formation requires cholesterol, this may explain why cho-
lesterol increases the size of glutamate receptor-mediated
postsynaptic currents [20]. The added cholesterol may
facilitate the clustering of postsynaptic receptors via rafts.
I should mention that most studies cited above detect only a
certain fraction of a given receptor protein in rafts suggest-
ing that receptors partition to raft and non-raft pools.
Indirect support for a postsynaptic function of rafts
comes from studies on a special intercellular connection
between non-neuronal cells, the so-called immunological
synapse. This synapse mediates T cell activation by antigen-
presenting cells [101]. Although this process is not yet fully
understood, it is well-established that signal transduction via
the postsynaptic T cell receptor and other signaling compo-
nents requires sequestration into a raft-like domain [76,101].
Interestingly, a recent study shows that the formation of the
immunological synapse is induced by the proteoglycan
agrin [102]. This suggests that the agrin-induced postsynap-
tic aggregation of AChRs in developing NMJs [103]
involves rafts as well.
Notably, raft association of transmitter receptors and
other PM components has only been shown biochemically
and a postsynaptic localization of receptor–raft complexes
has not been rigorously proven. It appears possible that
receptors localized in rafts represent an extrasynaptic
reserve pool, which allows for their recruitment to the PM
(Fig. 1) [96]. Thus, rafts may regulate the lateral mobility of
receptors [104,105] and determine their turnover rate in the
PM.
3.2.2. Cholesterol distribution in PMs
The spatial distribution of cholesterol in PMs has been
analysed in some of the freeze–fracture studies mentioned
above [64,66,67]. They report a low incidence of sterol–
filipin complexes in IMP-rich areas of the PM. This finding
comes as a surprise considering the biochemical evidence
that AChRs need to be embedded in a cholesterol-rich
microenvironment, in order to be functional [106–109]
(for review, see Ref. [34]). The discrepancy between bio-
chemical and cytochemical observations suggests that
sterol–filipin complexes do not fully record the ultrastruc-
tural distribution of cholesterol. To test for the presence of
rafts at synapses and to determine their relevance for
synapse function, new tools are needed to visualize lipid
microdomains and to monitor their dynamics [110].
3.3. Cholesterol and synaptic stability
The proposed link between cholesterol and synapse
development provokes thoughts about cholesterol and syn-
apse maintenance. Like other cellular structures, synapses
are dynamic assemblies of multiple elements, each of which
has a limited lifetime. The selective stabilization of synaptic
connections may underlie certain forms of structural plasti-
city [111], whereas failure to maintain them may lead to
neurodegeneration. Does cholesterol play a role in synapse
stabilization? In principle, the cholesterol-induced increase
in synapse number in cultured RGCs [20] could have been
caused by an increase in synapse stability: Cultured RGCs
may have continuously formed synapses, which perished
instantly due to a cholesterol deficit. Ullian et al. [27]
showed that removal of astrocytic feeding layers from
cultured RGCs reduces evoked autaptic transmission sug-
gesting that glia-derived factors regulate synapse stability.
So far, it is not clear, however, whether this factor is
cholesterol.
The structural stability of synapses depends on adhesion
molecules that tie the pre- and postsynaptic elements
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together. The intercellular adhesion may depend on choles-
terol considering evidence that different types of cell adhe-
sion molecules are localized in rafts (Fig. 1) including gly-
cophosphatidylinositol-linked proteins [112,113], NCAM
[114,115], integrins [116] and cadherins (for reviews, see
Refs. [75,76,117–119]). The recently discovered adhesion
molecule SynCAM, which appears involved in synapse
assembly [120], may localize to rafts as well. Future studies
need to address whether a cholesterol deficit impairs the
assembly of synaptic adhesion complexes and renders
synapses less stable.
4. Cholesterol and neurodegeneration
Cholesterol depletion has catastrophic consequences in
neuronal culture preparations: it leads to loss of vesicles and
exocytotic activity [72,73,89], inhibits neurite growth and
impairs neuronal survival [121–123]. These deleterious
effects may be caused by changes in membrane properties
including permeability and rigidity. However, there is also
evidence that the transduction of extracellular signals, which
are essential for neuronal growth and survival, breaks down
if cholesterol levels are insufficient. Recent studies have
shown that receptors for different growth factors like eph-
rins [98], glial cell line-derived neurotrophic factor [124],
neurotrophins [125] and neuregulins [126] (for reviews, see
Refs. [119,127]) are localized in cholesterol-rich rafts.
The observations in culture preparations predict that a
collapse of cholesterol homeostasis in vivo causes cell death.
Indeed, the massive neurodegeneration that occurs in Nie-
mann–Pick type C disease has been traced to a defect in
intracellular cholesterol transport [128,129]. The irreversible
loss of synapses and neurons that leads to the devastating
symptoms in Alzheimer’s disease (AD) [130] may also be
due to disturbance in the cholesterol homeostasis. The key
molecules that have been implied in AD [131–134] may
directly or indirectly perturb the synaptic cholesterol content.
The q4 allele of the ApoE gene, which raises the risk for late-
onset AD [132], may render lipoproteins less effective in
cholesterol transport from glia to neurons or modify choles-
terol release from astrocytes [135,136]. The peptide h-
amyloid (Ah), which is a proteolytic fragment of amyloid
precursor protein (APP) and a principal component of
extracellular plaques [133], has been shown to interfere with
cholesterol [13,16,127,137,138]. It induces loss of choles-
terol from cultured neurons [139,140] and changes the
fluidity of synaptosomal membranes [141]. Finally, its pro-
duction is influenced by cholesterol in vitro [142–147] and
in vivo [148], probably because the secretases, which cleave
APP, are localized in cholesterol-rich rafts [149–151].
Notably, a breakdown of cholesterol homeostasis may
also play a role in neurodegenerative processes that have not
been associated with this lipid so far. A recent study
suggests a link between cholesterol synthesis and Hunting-
ton disease (HD) [152]. HD is an autosomal recessive
disorder that leads to neurodegeneration in the striatum
and other brain regions. It is caused by expansions of
CAG repeats in the gene encoding for huntingtin, a ubiq-
uitously expressed protein of unknown function. HD
belongs to a large family of disorders that are due to
trinucleotide expansions in different genes [153,154]. Si-
pione et al. [152] used DNA microarrays to study how
mutant forms of huntingtin containing polyglutamine
stretches of different length affect gene expression in a
striatal cell line. Surprisingly, they found that induction of
huntingtin lowered the mRNA levels of several enzymes
involved in cholesterol synthesis. Although it is unclear how
huntingtin expression causes these changes, this observation
points to a role of deranged cholesterol homeostasis in HD
and other diseases involving trinucleotide expansions.
5. Conclusions and perspectives
The present synopsis shows that cholesterol is an essen-
tial component of synapses and predicts that their formation,
function and stability are sensitive to disturbances in cho-
lesterol metabolism. Evidently, numerous questions need to
be addressed: Do cholesterol levels limit synaptogenesis?
Do neurons depend on glia-derived cholesterol? Are cho-
lesterol-rich rafts essential for synapse formation, function
and stabilization? Do neurodegenerative diseases involve
defects in cholesterol homeostasis? Future studies on these
topics will require new experimental approaches to visualize
and manipulate cholesterol in a localized, cell-specific
manner. In any case, it appears timely to boost our efforts
to understand the neglected relation between cholesterol and
synapses.
Acknowledgements
I thank D. Dalencon for help with the literature search, G.
van Meer for helpful discussions and M. Muzet and L.
Surchev for valuable comments on the manuscript. Research
in my laboratory is supported by the Centre Nationale de
Recherche Scientifique, the Max-Planck-Gesellschaft, the
Fondation Pour La Recherche Medicale, the Fondation
Electricite´ de France, the Ara Parseghian Medical Research
Foundation, the Region Alsace and the Deutsche For-
schungsgemeinschaft.
References
[1] G.F. Gibbons, K.A. Mitropoulos, N.B. Myant, Biochemistry of Cho-
lesterol, Elsevier, Amsterdam, 1982.
[2] P.L. Yeagle, Cholesterol and the cell membrane, Biochim. Biophys.
Acta 822 (1985) 267–287.
[3] R.K. Mann, P.A. Beachy, Cholesterol modification of proteins, Bio-
chim. Biophys. Acta 1529 (2000) 188–202.
[4] R.V. Farese, J. Herz, Cholesterol metabolism and embryogenesis,
Trends Genet. 14 (1998) 115–120.
F.W. Pfrieger / Biochimica et Biophysica Acta 1610 (2003) 271–280276
[5] F.F. Moebius, B.U. Fitzky, H. Glossmann, Genetic defects in post-
squalene cholesterol biosynthesis, Trends Endocrinol. Metab. 11
(2000) 106–114.
[6] C. Roux, C. Wolf, N. Mulliez, W. Gaoua, V. Cormier, F. Chevy, D.
Citadelle, Role of cholesterol in embryonic development, Am. J.
Clin. Nutr. 71 (2000) 1270S–1279S.
[7] R.I. Kelley, G.E. Herman, Inborn errors of sterol biosynthesis, Annu.
Rev. Genomics Hum. Genet. 2 (2001) 299–341.
[8] N.A. Nwokoro, C.A. Wassif, F.D. Porter, Genetic disorders of cho-
lesterol biosynthesis in mice and humans, Mol. Genet. Metab. 74
(2001) 105–119.
[9] F.M. Sacks, Why cholesterol as a central theme in coronary artery
disease? Am. J. Cardiol. 82 (1998) 14T–17T.
[10] D.J. McNamara, Dietary cholesterol and atherosclerosis, Biochim.
Biophys. Acta 1529 (2000) 310–320.
[11] J.M. Opitz, E. Gilbert-Barness, J. Ackerman, A. Lowichik, Choles-
terol and development: the RSH (‘‘Smith –Lemli –Opitz’’) syn-
drome and related conditions, Pediatr. Pathol. Mol. Med. 21
(2002) 153–181.
[12] M.T. Vanier, Lipid changes in Niemann–Pick disease type C brain:
personal experience and review of the literature, Neurochem. Res. 24
(1999) 481–489.
[13] W.G. Wood, F. Schroeder, N.A. Avdulov, S.V. Chochina, U. Igbav-
boa, Recent advances in brain cholesterol dynamics: transport, do-
mains, and Alzheimer’s disease, Lipids 34 (1999) 225–234.
[14] E.E. Baulieu, P. Robel, M. Schumacher, Neurosteroids: beginning of
the story, Int. Rev. Neurobiol. 46 (2001) 1–32.
[15] J.M. Dietschy, S.D. Turley, Cholesterol metabolism in the brain,
Curr. Opin. Lipidol. 12 (2001) 105–112.
[16] G. Schmitz, E. Orso, Intracellular cholesterol and phospholipid traf-
ficking: comparable mechanisms in macrophages and neuronal cells,
Neurochem. Res. 26 (2001) 1045–1068.
[17] B. Stoffel-Wagner, Neurosteroid metabolism in the human brain,
Eur. J. Endocrinol. 145 (2001) 669–679.
[18] S.H. Mellon, L.D. Griffin, Neurosteroids: biochemistry and clinical
significance, Trends Endocrinol. Metab. 13 (2002) 35–43.
[19] W.J. Strittmatter, H.C. Bova, Molecular biology of apolipoprotein E,
Curr. Opin. Lipidol. 13 (2002) 119–123.
[20] D.H. Mauch, K. Na¨gler, S. Schumacher, C. Go¨ritz, E.C. Mu¨ller, A.
Otto, F.W. Pfrieger, CNS synaptogenesis promoted by glia-derived
cholesterol, Science 294 (2001) 1354–1357.
[21] C. Go¨ritz, D.H.. Mauch, K. Na¨gler, F.W. Pfrieger, Role of glia-de-
rived cholesterol in synaptogenesis: new revelations in the synapse–
glia affair, J. Physiol. (Paris) 96 (2002) 257–263.
[22] F.W. Pfrieger, The role of glia in the development of synaptic con-
tacts, in: A. Volterra, P.J. Magistretti, P.G. Haydon (Eds.), Tripartite
Synapses: Synaptic Transmission with Glia, Oxford Univ. Press,
Oxford, 2002, pp. 24–34. Chapter 2.
[23] F.W. Pfrieger, Role of glia in synapse development, Curr. Opin.
Neurobiol. 12 (2002) 486–490.
[24] F.W. Pfrieger, Outsourcing in the brain: Do neurons depend on
cholesterol delivery by astrocytes? BioEssays 25 (2003) 72–78.
[25] F.W. Pfrieger, B.A. Barres, Synaptic efficacy enhanced by glial cells,
Science 277 (1997) 1684–1687.
[26] K. Na¨gler, D.H. Mauch, F.W. Pfrieger, Glia-derived signals induce
synapse formation in neurones of the rat central nervous system, J.
Physiol. 533 (2001) 665–679.
[27] E.M. Ullian, S.K. Sapperstein, K.S. Christopherson, B.A. Barres,
Control of synapse number by glia, Science 291 (2001) 657–661.
[28] M. Jacobson, Developmental Neurobiology, Plenum, New York,
1991.
[29] F.W. Pfrieger, B.A. Barres, New views on synapse–glia interactions,
Curr. Opin. Neurobiol. 6 (1996) 615–621.
[30] B.A. Barres, B.E. Silverstein, D.P. Corey, L.L.Y. Chun, Immunolog-
ical, morphological, and electrophysiological variation among retinal
ganglion cells purified by panning, Neuron 1 (1988) 791–803.
[31] A. Meyer-Franke, M.R. Kaplan, F.W. Pfrieger, B.A. Barres, Char-
acterization of the signaling interactions that promote the survival
and growth of developing retinal ganglion cells in culture, Neuron
15 (1995) 805–819.
[32] A.A. Spector, M.A. Yorek, Membrane lipid composition and cellular
function, J. Lipid Res. 26 (1985) 1015–1035.
[33] P.L. Yeagle, Lipid regulation of cell membrane structure and func-
tion, FASEB J. 3 (1989) 1833–1842.
[34] F.J. Barrantes, Structural – functional correlates of the nicotinic ace-
tylcholine receptor and its lipid microenvironment, FASEB J. 7
(1993) 1460–1467.
[35] E.M. Bastiaanse, K.M. Hold, L.A. Van der, The effect of membrane
cholesterol content on ion transport processes in plasma membranes,
Cardiovasc. Res. 33 (1997) 272–283.
[36] K. Burger, G. Gimpl, F. Fahrenholz, Regulation of receptor function
by cholesterol, Cell. Mol. Life Sci. 57 (2000) 1577–1592.
[37] D.G. Jones, Synapses and Synaptosomes: Morphological Aspects,
Chapman & Hall, London, 1975.
[38] V.P. Whittaker, 30 years of synaptosome research, J. Neurocytol. 22
(1993) 735–742.
[39] V.P. Whittaker, Some properties of synaptic membranes isolated
from the central nervous system, Ann. N.Y. Acad. Sci. 137 (1966)
982–998.
[40] E.G. Lapetina, E.F. Soto, E. De Robertis, Lipids and proteolipids in
isolated subcellular membranes of rat brain cortex, J. Neurochem. 15
(1968) 437–445.
[41] C. Cotman, M.L. Blank, A. Moehl, F. Snyder, Lipid composition of
synaptic plasma membranes isolated from rat brain by zonal centri-
fugation, Biochemistry 8 (1969) 4606–4612.
[42] R.G. Simon, M. Gill, N. Lemkey-Johnston, L.M. Larramendi, Cho-
lesterol and phospholipid composition of cerebellar fractions en-
riched in unmyelinated axons and synaptosomes, Exp. Brain Res.
13 (1971) 504–513.
[43] S.E. Kornguth, A.L. Flangas, R.L. Geison, G. Scott, Morphology,
isopycnic density and lipid content of synaptic complexes isolated
from developing cerebellums and different brain regions, Brain Res.
37 (1972) 53–68.
[44] R.J. Hitzemann, D.A. Johnson, Developmental changes in synaptic
membrane lipid composition and fluidity, Neurochem. Res. 8 (1983)
121–131.
[45] M. Igarashi, H. Waki, M. Hirota, Y. Hirabayashi, K. Obata, S. Ando,
Differences in lipid composition between isolated growth cones from
the forebrain and those from the brainstem in the fetal rat, Brain
Res., Dev. Brain Res. 51 (1990) 1–9.
[46] W.G. Wood, R. Strong, L.S. Williamson, R.W. Wise, Changes in
lipid composition of cortical synaptosomes from different age groups
of mice, Life Sci. 35 (1984) 1947–1952.
[47] G.P. Eckert, W.G. Wood, W.E. Muller, Effects of aging and beta-
amyloid on the properties of brain synaptic and mitochondrial mem-
branes, J. Neural Transm. 108 (2001) 1051–1064.
[48] R.C. Johnson, C.M. McKean, S.N. Shah, Fatty acid composition of
lipids in cerebral myelin and synaptosomes in phenylketonuria and
Down syndrome, Arch. Neurol. 34 (1977) 288–294.
[49] W.G. Wood, F. Schroeder, L. Hogy, A.M. Rao, G. Nemecz, Asym-
metric distribution of a fluorescent sterol in synaptic plasma mem-
branes: effects of chronic ethanol consumption, Biochim. Biophys.
Acta 1025 (1990) 243–246.
[50] T.L. Smith, Synaptosomal cholesterol and phospholipid levels in
several mouse strains differentially sensitive to ethanol, J. Pharma-
col. Exp. Ther. 232 (1985) 702–707.
[51] U. Igbavboa, N.A. Avdulov, F. Schroeder, W.G. Wood, Increasing
age alters transbilayer fluidity and cholesterol asymmetry in synaptic
plasma membranes of mice, J. Neurochem. 66 (1996) 1717–1725.
[52] U. Igbavboa, N.A. Avdulov, S.V. Chochina, W.G. Wood, Transbi-
layer distribution of cholesterol is modified in brain synaptic plasma
membranes of knockout mice deficient in the low-density lipopro-
tein receptor, apolipoprotein E, or both proteins, J. Neurochem. 69
(1997) 1661–1667.
F.W. Pfrieger / Biochimica et Biophysica Acta 1610 (2003) 271–280 277
[53] H. Hayashi, U. Igbavboa, H. Hamanaka, M. Kobayashi, S.C. Fujita,
W.G. Wood, K. Yanagisawa, Cholesterol is increased in the exofacial
leaflet of synaptic plasma membranes of human apolipoprotein E4
knock-in mice, NeuroReport 13 (2002) 383–386.
[54] R.J. Raggers, T. Pomorski, J.C. Holthuis, N. Kalin, G. van Meer,
Lipid traffic: the ABC of transbilayer movement, Traffic 1 (2000)
226–234.
[55] L. Liscum, N.J. Munn, Intracellular cholesterol transport, Biochim.
Biophys. Acta 1438 (1999) 19–37.
[56] L.M. Loura, A. Fedorov, M. Prieto, Exclusion of a cholesterol ana-
log from the cholesterol-rich phase in model membranes, Biochim.
Biophys. Acta 1511 (2001) 236–243.
[57] A. Papaphilis, G. Deliconstantinos, Modulation of serotonergic re-
ceptors by exogenous cholesterol in the dog synaptosomal plasma
membrane, Biochem. Pharmacol. 29 (1980) 3325–3327.
[58] H.K. Shapiro, R.L. Barchi, Alteration of synaptosomal plasma mem-
brane cholesterol content: membrane physical properties and cation
transport proteins, J. Neurochem. 36 (1981) 1813–1818.
[59] P. North, S. Fleischer, Alteration of synaptic membrane cholesterol/
phospholipid ratio using a lipid transfer protein. Effect on gamma-
aminobutyric acid uptake, J. Biol. Chem. 258 (1983) 1242–1253.
[60] G. Deliconstantinos, Structure activity relationship of cholesterol
and steroid hormones with respect to their effects on the Ca2 +-
stimulated ATPase and lipid fluidity of synaptosomal plasma mem-
branes from dog and rabbit brain, Comp. Biochem. Physiol., B 89
(1988) 585–594.
[61] P.A. Maguire, M.J. Druse, The influence of cholesterol on synaptic
fluidity, dopamine D1 binding and dopamine-stimulated adenylate
cyclase, Brain Res. Bull. 23 (1989) 69–74.
[62] K.P. Whiting, C.J. Restall, P.F. Brain, Steroid hormone-induced ef-
fects on membrane fluidity and their potential roles in non-genomic
mechanisms, Life Sci. 67 (2000) 743–757.
[63] N.J. Severs, H. Robenek, Detection of microdomains in biomem-
branes. An appraisal of recent developments in freeze– fracture cy-
tochemistry, Biochim. Biophys. Acta 737 (1983) 373–408.
[64] Y. Nakajima, P.C. Bridgman, Absence of filipin–sterol complexes
from the membranes of active zones and acetylcholine receptor ag-
gregates at frog neuromuscular junctions, J. Cell Biol. 88 (1981)
453–458.
[65] C.P. Ko, J.W. Propst, Absence of sterol-specific complexes at active
zones of degenerating and regenerating frog neuromuscular junc-
tions, J. Neurocytol. 15 (1986) 231–240.
[66] N.G. Cooper, B.J. McLaughlin, The distribution of filipin–sterol
complexes in photoreceptor synaptic membranes, J. Comp. Neurol.
230 (1984) 437–443.
[67] A. Perrelet, L.M. Garcia-Segura, A. Singh, L. Orgi, Distribution
of cytochemically detectable cholesterol in the electric organ of
Torpedo marmorata, Proc. Natl. Acad. Sci. U. S. A. 79 (1982)
2598–2602.
[68] J. Renau-Piqueras, F. Miragall, A. Marques, R. Baguena-Cervellera,
C. Guerri, Chronic ethanol consumption affects filipin–cholesterol
complexes and intramembranous particles of synaptosomes of rat
brain cortex, Alcohol Clin. Exp. Res. 11 (1987) 486–493.
[69] L. Surchev, V. Dontchev, K. Ichev, S. Dolapchieva, A. Bozhilova-
Pastirova, M. Vankova, E. Kirazov, E. Vassileva, L. Venkov,
Changes in the neuronal plasma membrane during synaptogenesis,
Cell Mol. Biol. (Noisy-le-grand) 41 (1995) 1073–1080.
[70] G. Egea, J. Marsal, C. Solsona, X. Rabasseda, J. Blasi, Increase in
reactive cholesterol in the presynaptic membrane of depolarized
Torpedo synaptosomes: blockade by botulinum toxin type A, Neuro-
science 31 (1989) 521–527.
[71] R.G. Miller, The use and abuse of filipin to localize cholesterol in
membranes, Cell Biol., Int. Rep. 8 (1984) 519–535.
[72] T. Lang, D. Bruns, D. Wenzel, D. Riedel, P. Holroyd, C. Thiele, R.
Jahn, SNAREs are concentrated in cholesterol-dependent clusters
that define docking and fusion sites for exocytosis, EMBO J. 20
(2001) 2202–2213.
[73] L.H. Chamberlain, R.D. Burgoyne, G.W. Gould, SNARE proteins
are highly enriched in lipid rafts in PC12 cells: implications for the
spatial control of exocytosis, Proc. Natl. Acad. Sci. U. S. A. 98
(2001) 5619–5624.
[74] K. Simons, E. Ikonen, Functional rafts in cell membranes, Nature
387 (1997) 569–572.
[75] D.A. Brown, E. London, Functions of lipid rafts in biological mem-
branes, Annu. Rev. Cell Dev. Biol. 14 (1998) 111–136.
[76] K. Simons, D. Toomre, Lipid rafts and signal transduction, Nat.
Rev., Mol. Cell Biol. 1 (2000) 31–39.
[77] E. Ikonen, Roles of lipid rafts in membrane transport, Curr. Opin.
Cell Biol. 13 (2001) 470–477.
[78] T.V. Kurzchalia, R.G. Parton, Membrane microdomains and caveo-
lae, Curr. Opin. Cell Biol. 11 (1999) 424–431.
[79] H. Zimmermann, Biochemistry of the isolated cholinergic vesicle,
in: R.L. Klein, H. Lagercrantz, H. Zimmermann (Eds.), Neurotrans-
mitter Vesicles, Academic Press, London, 1982, pp. 271–304.
[80] W.C. Breckenridge, I.G. Morgan, J.P. Zanetta, G. Vincendon, Adult
rat brain synaptic vesicles: II. Lipid composition, Biochim. Biophys.
Acta 320 (1973) 681–686.
[81] A. Nagy, R.R. Baker, S.J. Morris, V.P. Whittaker, The preparation
and characterization of synaptic vesicles of high purity, Brain Res.
109 (1976) 285–309.
[82] J.A. Wagner, S.S. Carlson, R.B. Kelly, Chemical and physical char-
acterization of cholinergic synaptic vesicles, Biochemistry 17 (1978)
1199–1206.
[83] J.W. Deutsch, R.B. Kelly, Lipids of synaptic vesicles: relevance to
the mechanism of membrane fusion, Biochemistry 20 (1981)
378–385.
[84] G.H. DeVries, W.J. Zetusky, C. Zmachinski, V.P. Calabrese, Lipid
composition of axolemma-enriched fractions from human brains, J.
Lipid Res. 22 (1981) 208–216.
[85] S. Takamori, J.S. Rhee, C. Rosenmund, R. Jahn, Identification of a
vesicular glutamate transporter that defines a glutamatergic pheno-
type in neurons, Nature 407 (2000) 189–194.
[86] W.B. Huttner, J. Zimmerberg, Implications of lipid microdomains
for membrane curvature, budding and fission, Curr. Opin. Cell Biol.
13 (2001) 478–484.
[87] M.E. Haque, T.J. McIntosh, B.R. Lentz, Influence of lipid compo-
sition on physical properties and peg-mediated fusion of curved and
uncurved model membrane vesicles: ‘‘nature’s own’’ fusogenic lipid
bilayer, Biochemistry 40 (2001) 4340–4348.
[88] M.J. Hannah, A.A. Schmidt, W.B. Huttner, Synaptic vesicle biogen-
esis, Annu. Rev. Cell Dev. Biol. 15 (1999) 733–798.
[89] C. Thiele, M.J. Hannah, F. Fahrenholz, W.B. Huttner, Cholesterol
binds to synaptophysin and is required for biogenesis of synaptic
vesicles, Nat. Cell Biol. 2 (2000) 42–49.
[90] T.F. Martin, Racing lipid rafts for synaptic-vesicle formation, Nat.
Cell Biol. 2 (2000) E9–E11.
[91] D.R. Klopfenstein, M. Tomishige, N. Stuurman, R.D. Vale, Role of
phosphatidylinositol(4,5)bisphosphate organization in membrane
transport by the Unc104 kinesin motor, Cell 109 (2002) 347–358.
[92] C.C. Garner, J. Nash, R.L. Huganir, PDZ domains in synapse as-
sembly and signalling, Trends Cell Biol. 10 (2000) 274–280.
[93] M.B. Kennedy, Signal-processing machines at the postsynaptic den-
sity, Science 290 (2000) 750–754.
[94] M. Sheng, D.T. Pak, Ligand-gated ion channel interactions with
cytoskeletal and signaling proteins, Annu. Rev. Physiol. 62 (2000)
755–778.
[95] J.L. Bruses, N. Chauvet, U. Rutishauser, Membrane lipid rafts are
necessary for the maintenance of the (alpha)7 nicotinic acetylcholine
receptor in somatic spines of ciliary neurons, J. Neurosci. 21 (2001)
504–512.
[96] T. Suzuki, J. Ito, H. Takagi, F. Saitoh, H. Nawa, H. Shimizu, Bio-
chemical evidence for localization of AMPA-type glutamate receptor
subunits in the dendritic raft, Brain Res., Mol. Brain Res. 89 (2001)
20–28.
F.W. Pfrieger / Biochimica et Biophysica Acta 1610 (2003) 271–280278
[97] A.S. Perez, D.S. Bredt, The N-terminal PDZ-containing region of
postsynaptic density-95 mediates association with caveolar-like lipid
domains, Neurosci. Lett. 258 (1998) 121–123.
[98] K. Bruckner, L.J. Pablo, P. Scheiffele, A. Herb, P.H. Seeburg, R.
Klein, EphrinB ligands recruit GRIP family PDZ adaptor proteins
into raft membrane microdomains, Neuron 22 (1999) 511–524.
[99] A. Becher, J.H. White, R.A. McIlhinney, The gamma-aminobutyric
acid receptor B, but not the metabotropic glutamate receptor type-1,
associates with lipid rafts in the rat cerebellum, J. Neurochem. 79
(2001) 787–795.
[100] L. Fallon, F. Moreau, B.G. Croft, N. Labib, W.J. Gu, E.A. Fon,
Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction
and are co-localized in lipid rafts and postsynaptic densities in brain,
J. Biol. Chem. 277 (2002) 486–491.
[101] S.K. Bromley, W.R. Burack, K.G. Johnson, K. Somersalo, T.N.
Sims, C. Sumen, M.M. Davis, A.S. Shaw, P.M. Allen, M.L. Dustin,
The immunological synapse, Annu. Rev. Immunol. 19 (2001)
375–396.
[102] A.A. Khan, C. Bose, L.S. Yam, M.J. Soloski, F. Rupp, Physiological
regulation of the immunological synapse by agrin, Science 292
(2001) 1681–1686.
[103] J.R. Sanes, J.W. Lichtman, Induction, assembly, maturation and
maintenance of a postsynaptic apparatus, Nat. Rev., Neurosci. 2
(2001) 791–805.
[104] J. Meier, C. Vannier, A. Serge, A. Triller, D. Choquet, Fast and
reversible trapping of surface glycine receptors by gephyrin, Nat.
Neurosci. 4 (2001) 253–260.
[105] A.J. Borgdorff, D. Choquet, Regulation of AMPA receptor lateral
movements, Nature 417 (2002) 649–653.
[106] J.L. Popot, R.A. Demel, A. Sobel, L.L. van Deenen, J.P. Changeux,
Interaction of the acetylcholine (nicotinic) receptor protein from
Torpedo marmorata electric organ with monolayers of pure lipids,
Eur. J. Biochem. 85 (1978) 27–42.
[107] W. Schiebler, F. Hucho, Membranes rich in acetylcholine receptor:
characterization and reconstitution to excitable membranes from
exogenous lipids, Eur. J. Biochem. 85 (1978) 55–63.
[108] W.S. Leibel, L.L. Firestone, D.C. Legler, L.M. Braswell, K.W. Mill-
er, Two pools of cholesterol in acetylcholine receptor-rich mem-
branes from Torpedo, Biochim. Biophys. Acta 897 (1987) 249–260.
[109] O.T. Jones, M.G. McNamee, Annular and nonannular binding sites
for cholesterol associated with the nicotinic acetylcholine receptor,
Biochemistry 27 (1988) 2364–2374.
[110] D.A. Zacharias, J.D. Violin, A.C. Newton, R.Y. Tsien, Partitioning
of lipid-modified monomeric GFPs into membrane microdomains of
live cells, Science 296 (2002) 913–916.
[111] J.W. Lichtman, H. Colman, Synapse elimination and indelible mem-
ory, Neuron 25 (2000) 269–278.
[112] M. Buttiglione, J.M. Revest, O. Pavlou, D. Karagogeos, A. Furley,
G. Rougon, C. Faivre-Sarrailh, A functional interaction between the
neuronal adhesion molecules TAG-1 and F3 modulates neurite out-
growth and fasciculation of cerebellar granule cells, J. Neurosci. 18
(1998) 6853–6870.
[113] D.M. Lang, S. Lommel, M. Jung, R. Ankerhold, B. Petrausch, U.
Laessing, M.F. Wiechers, H. Plattner, C.A. Stuermer, Identification
of reggie-1 and reggie-2 as plasma membrane-associated proteins
which cocluster with activated GPI-anchored cell adhesion mole-
cules in non-caveolar micropatches in neurons, J. Neurobiol. 37
(1998) 502–523.
[114] Q. He, K.F. Meiri, Isolation and characterization of detergent-resist-
ant microdomains responsive to NCAM-mediated signaling from
growth cones, Mol. Cell. Neurosci. 19 (2002) 18–31.
[115] P. Niethammer, M. Delling, V. Sytnyk, A. Dityatev, K. Fukami, M.
Schachner, Cosignaling of NCAM via lipid rafts and the FGF
receptor is required for neuritogenesis, J. Cell Biol. 157 (2002)
521–532.
[116] B. Leitinger, N. Hogg, The involvement of lipid rafts in the regu-
lation of integrin function, J. Cell Sci. 115 (2002) 963–972.
[117] K.L. Crossin, L.A. Krushel, Cellular signaling by neural cell adhe-
sion molecules of the immunoglobulin superfamily, Dev. Dyn. 218
(2000) 260–279.
[118] B.D. Angst, C. Marcozzi, A.I. Magee, The cadherin superfamily:
diversity in form and function, J. Cell Sci. 114 (2001) 629–641.
[119] B.A. Tsui-Pierchala, M. Encinas, J. Milbrandt, E.M. Johnson Jr.,
Lipid rafts in neuronal signaling and function, Trends Neurosci. 25
(2002) 412–417.
[120] T. Biederer, Y. Sara, M. Mozhayeva, D. Atasoy, X. Liu, E.T. Kava-
lali, T.C. Sudhof, SynCAM, a synaptic adhesion molecule that drives
synapse assembly, Science 297 (2002) 1525–1531.
[121] E.I. de Chaves, A.E. Rusinol, D.E. Vance, R.B. Campenot, J.E.
Vance, Role of lipoproteins in the delivery of lipids to axons during
axonal regeneration, J. Biol. Chem. 272 (1997) 30766–30773.
[122] M. Michikawa, K. Yanagisawa, Inhibition of cholesterol production
but not of nonsterol isoprenoid products induces neuronal cell death,
J. Neurochem. 72 (1999) 2278–2285.
[123] Q.W. Fan, W. Yu, T. Senda, K. Yanagisawa, M. Michikawa, Choles-
terol-dependent modulation of tau phosphorylation in cultured neu-
rons, J. Neurochem. 76 (2001) 391–400.
[124] G. Paratcha, F. Ledda, L. Baars, M. Coulpier, V. Besset, J. Anders,
R. Scott, C.F. Ibanez, Released GFRalpha1 potentiates downstream
signaling, neuronal survival, and differentiation via a novel mech-
anism of recruitment of c-Ret to lipid rafts, Neuron 29 (2001)
171–184.
[125] L.P. Henderson, L. Lin, A. Prasad, C.A. Paul, T.Y. Chang, R.A.
Maue, Embryonic striatal neurons from Niemann–Pick type C mice
exhibit defects in cholesterol metabolism and neurotrophin respon-
siveness, J. Biol. Chem. 275 (2000) 20179–20187.
[126] K.E. Frenzel, D.L. Falls, Neuregulin-1 proteins in rat brain and
transfected cells are localized to lipid rafts, J. Neurochem. 77
(2001) 1–12.
[127] C. Lynch, W. Mobley, Comprehensive theory of Alzheimer’s dis-
ease. The effects of cholesterol on membrane receptor trafficking,
Ann. N.Y. Acad. Sci. 924 (2000) 104–111.
[128] E.D. Carstea, J.A. Morris, K.G. Coleman, S.K. Loftus, D. Zhang, C.
Cummings, J. Gu, M.A. Rosenfeld, W.J. Pavan, D.B. Krizman, J.
Nagle, M.H. Polymeropoulos, S.L. Sturley, Y.A. Ioannou, M.E.
Higgins, M. Comly, A. Cooney, A. Brown, C.R. Kaneski, E.J.
Blanchette-Mackie, N.K. Dwyer, E.B. Neufeld, T.Y. Chang, L.
Liscum, J.F. Strauss III, K. Ohno, M. Zeigler, R. Carmi, J. Sokol,
D. Markie, R.R. O’Neill, O.P. van Diggelen, M. Elleder, M.C.
Patterson, R.O. Brady, M.T. Vanier, P.G. Pentchev, D.A. Tagle,
Niemann–Pick C1 disease gene: homology to mediators of choles-
terol homeostasis, Science 277 (1997) 228–231.
[129] S.K. Loftus, J.A. Morris, E.D. Carstea, J.Z. Gu, C. Cummings, A.
Brown, J. Ellison, K. Ohno, M.A. Rosenfeld, D.A. Tagle, P.G.
Pentchev, W.J. Pavan, Murine model of Niemann–Pick C disease:
mutation in a cholesterol homeostasis gene, Science 277 (1997)
232–235.
[130] H. Lassmann, Patterns of synaptic and nerve cell pathology in Alz-
heimer’s disease, Behav. Brain Res. 78 (1996) 9–14.
[131] U. Beffert, M. Danik, P. Krzywkowski, C. Ramassamy, F. Berrada,
J. Poirier, The neurobiology of apolipoproteins and their receptors
in the CNS and Alzheimer’s disease, Brain Res. Rev. 27 (1998)
119–142.
[132] P.H. George-Hyslop, Molecular genetics of Alzheimer’s disease,
Biol. Psychiatry 47 (2000) 183–199.
[133] D.J. Selkoe, Alzheimer’s disease: genes, proteins, and therapy, Phys-
iol. Rev. 81 (2001) 741–766.
[134] F. Richard, P. Amouyel, Genetic susceptibility factors for Alzheim-
er’s disease, Eur. J. Pharmacol. 412 (2001) 1–12.
[135] M. Michikawa, Q.W. Fan, I. Isobe, K. Yanagisawa, Apolipoprotein
E exhibits isoform-specific promotion of lipid efflux from astrocytes
and neurons in culture, J. Neurochem. 74 (2000) 1008–1016.
[136] J.S. Gong, M. Kobayashi, H. Hayashi, K. Zou, N. Sawamura, S.C.
Fujita, K. Yanagisawa, M. Michikawa, Apolipoprotein E (ApoE)
F.W. Pfrieger / Biochimica et Biophysica Acta 1610 (2003) 271–280 279
isoform-dependent lipid release from astrocytes prepared from hu-
man ApoE3 and ApoE4 knock-in mice, J. Biol. Chem. 277 (2002)
29919–29926.
[137] J. Poirier, Apolipoprotein E and Alzheimer’s disease. A role in amy-
loid catabolism, Ann. N.Y. Acad. Sci. 924 (2000) 81–90.
[138] T. Hartmann, Cholesterol, A beta and Alzheimer’s disease, Trends
Neurosci. 24 (2001) S45–S48.
[139] N.V. Koudinova, A.R. Koudinov, E. Yavin, Alzheimer’s Abeta1–40
peptide modulates lipid synthesis in neuronal cultures and intact rat
fetal brain under normoxic and oxidative stress conditions, Neuro-
chem. Res. 25 (2000) 653–660.
[140] M. Michikawa, J.S. Gong, Q.W. Fan, N. Sawamura, K. Yanagisa-
wa, A novel action of Alzheimer’s amyloid beta-protein (Abeta):
oligomeric Abeta promotes lipid release, J. Neurosci. 21 (2001)
7226–7235.
[141] S.V. Chochina, N.A. Avdulov, U. Igbavboa, J.P. Cleary, E.O. O’Hare,
W.G. Wood, Amyloid beta-peptide1–40 increases neuronal mem-
brane fluidity: role of cholesterol and brain region, J. Lipid Res. 42
(2001) 1292–1297.
[142] S. Bodovitz, W.L. Klein, Cholesterol modulates alpha-secretase
cleavage of amyloid precursor protein, J. Biol. Chem. 271 (1996)
4436–4440.
[143] M. Simons, P. Keller, B. De Strooper, K. Beyreuther, C.G. Dotti, K.
Simons, Cholesterol depletion inhibits the generation of beta-amy-
loid in hippocampal neurons, Proc. Natl. Acad. Sci. U. S. A. 95
(1998) 6460–6464.
[144] E.R. Frears, D.J. Stephens, C.E. Walters, H. Davies, B.M. Austen,
The role of cholesterol in the biosynthesis of beta-amyloid, Neuro-
Report 10 (1999) 1699–1705.
[145] E. Kojro, G. Gimpl, S. Lammich, W. Marz, F. Fahrenholz, Low
cholesterol stimulates the nonamyloidogenic pathway by its effect
on the alpha-secretase ADAM 10, Proc. Natl. Acad. Sci. U. S. A. 98
(2001) 5815–5820.
[146] S.R. Ji, Y. Wu, S.F. Sui, Cholesterol is an important factor affecting
the membrane insertion of beta-amyloid peptide (A beta 1–40),
which may potentially inhibit the fibril formation, J. Biol. Chem.
277 (2002) 6273–6279.
[147] H. Runz, J. Rietdorf, I. Tomic, M. de Bernard, K. Beyreuther, R.
Pepperkok, T. Hartmann, Inhibition of intracellular cholesterol trans-
port alters presenilin localization and amyloid precursor protein pro-
cessing in neuronal cells, J. Neurosci. 22 (2002) 1679–1689.
[148] L.M. Refolo, M.A. Pappolla, J. LaFrancois, B. Malester, S.D.
Schmidt, T. Thomas-Bryant, G.S. Tint, R. Wang, M. Mercken,
S.S. Petanceska, K.E. Duff, A cholesterol-lowering drug reduces
beta-amyloid pathology in a transgenic mouse model of Alzheimer’s
disease, Neurobiol. Dis. 8 (2001) 890–899.
[149] S.J. Lee, U. Liyanage, P.E. Bickel, W. Xia, P.T. Lansbury Jr., K.S.
Kosik, A detergent-insoluble membrane compartment contains A
beta in vivo, Nat. Med. 4 (1998) 730–734.
[150] D.R. Riddell, G. Christie, I. Hussain, C. Dingwall, Compartmental-
ization of beta-secretase (Asp2) into low-buoyant density, noncaveo-
lar lipid rafts, Curr. Biol. 11 (2001) 1288–1293.
[151] S. Wahrle, P. Das, A.C. Nyborg, C. McLendon, M. Shoji, T. Kawar-
abayashi, L.H. Younkin, S.G. Younkin, T.E. Golde, Cholesterol-
dependent gamma-secretase activity in buoyant cholesterol-rich
membrane microdomains, Neurobiol. Dis. 9 (2002) 11–23.
[152] S. Sipione, D. Rigamonti, M. Valenza, C. Zuccato, L. Conti, J.
Pritchard, C. Kooperberg, J.M. Olson, E. Cattaneo, Early transcrip-
tional profiles in huntingtin-inducible striatal cells by microarray
analyses, Hum. Mol. Genet. 11 (2002) 1953–1965.
[153] C.J. Cummings, H.Y. Zoghbi, Trinucleotide repeats: mechanisms
and pathophysiology, Annu. Rev. Genomics Hum. Genet. 1 (2000)
281–328.
[154] H.T. Orr, Beyond the Qs in the polyglutamine diseases, Genes Dev.
15 (2001) 925–932.
F.W. Pfrieger / Biochimica et Biophysica Acta 1610 (2003) 271–280280
